Mostrar el registro sencillo del ítem

dc.contributor.author
Fernández Romero, Lucía  
dc.contributor.author
Morello García, Florentina  
dc.contributor.author
Laforce, Robert Jr.  
dc.contributor.author
Delgado Alonso, Cristina  
dc.contributor.author
Delgado Álvarez, Alfonso  
dc.contributor.author
Gil Moreno, María José  
dc.contributor.author
Lavoie, Monica  
dc.contributor.author
Matias Guiu, Jorge  
dc.contributor.author
Cuetos, Fernando  
dc.contributor.author
Matias Guiu, Jordi  
dc.date.available
2025-07-14T15:01:32Z  
dc.date.issued
2024-10  
dc.identifier.citation
Fernández Romero, Lucía; Morello García, Florentina; Laforce, Robert Jr.; Delgado Alonso, Cristina; Delgado Álvarez, Alfonso; et al.; Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia; IOS Press; Journal of Alzheimer's Disease; 102; 1; 10-2024; 67-76  
dc.identifier.issn
1387-2877  
dc.identifier.uri
http://hdl.handle.net/11336/265972  
dc.description.abstract
Background: Clinical diagnosis in primary progressive aphasia (PPA) is challenging. Recently, emphasis has been placed on the importance of screening evaluation. Three different screening tests that use different strategies based on the assessment of language (Mini-Linguistic State Examination, MLSE) or different cognitive domains (Addenbrooke’s Cognitive Examination, ACE-III and Dépistage Cognitif de Québec, DCQ) have been proposed and independently validated. These tests aim to detect PPA and classify into the three main variants (non-fluent (nfvPPA), semantic (svPPA) and logopenic (lvPPA)). Objective: This study aims to evaluate and compare the diagnostic capacity of these three instruments in PPA. Methods: A cross-sectional study including 43 patients with PPA (nfvPPA (n = 19), svPPA (n = 8), and lvPPA (n = 16)) and 21 cognitively unimpaired controls was conducted. Clinical diagnoses were established based on an extensive multidisciplinary assessment including neuropsychological assessment, fluorodeoxyglucose-positron emission tomography, MRI, and cerebrospinal fluid biomarkers. Both PPA patients and controls completed the three tests (MLSE, ACE-III, and DCQ). Results: Internal consistency was excellent for the three tests. The area under the curve for the diagnosis of PPA was 0.950 for MLSE, 0.953 for ACE-III, and 0.933 for DCQ. Correlations between the three tests were high. The MLSE, ACE-III, and DCQ tests obtained adequate levels of discrimination between the variants of PPA, with accuracies between 76–79%. Conclusions: This study confirms the validity of ACE-III, MLSE, and DCQ for the diagnosis of PPA and its variants. This suggests that detailed assessment of linguistic characteristics (MLSE) and non-linguistic features (DCQ, ACE-III) are relevant for the diagnosis and classification of PPA.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
IOS Press  
dc.rights
info:eu-repo/semantics/restrictedAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
ALZHEIMERS DISEASE  
dc.subject
FRONTOTEMPORAL DEMENTIA  
dc.subject
NEUROPSYCHOLOGICAL ASSESSMENT  
dc.subject
PRIMARY PROGRESSIVE APHASIA  
dc.subject
SCREENING  
dc.subject.classification
Neurociencias  
dc.subject.classification
Medicina Básica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.subject.classification
Otras Psicología  
dc.subject.classification
Psicología  
dc.subject.classification
CIENCIAS SOCIALES  
dc.title
Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2025-07-14T11:11:53Z  
dc.journal.volume
102  
dc.journal.number
1  
dc.journal.pagination
67-76  
dc.journal.pais
Países Bajos  
dc.journal.ciudad
Amsterdam  
dc.description.fil
Fil: Fernández Romero, Lucía. Hospital Clínico San Carlos; España  
dc.description.fil
Fil: Morello García, Florentina. Universidad de Buenos Aires. Facultad de Psicología; Argentina. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia. Instituto de Neurociencias - Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de Neurociencias; Argentina  
dc.description.fil
Fil: Laforce, Robert Jr.. Laval University; Canadá  
dc.description.fil
Fil: Delgado Alonso, Cristina. Hospital Clínico San Carlos; España  
dc.description.fil
Fil: Delgado Álvarez, Alfonso. Hospital Clínico San Carlos; España. Universidad Complutense de Madrid; España  
dc.description.fil
Fil: Gil Moreno, María José. Hospital Clínico San Carlos; España  
dc.description.fil
Fil: Lavoie, Monica. Laval University; Canadá  
dc.description.fil
Fil: Matias Guiu, Jorge. Hospital Clínico San Carlos; España  
dc.description.fil
Fil: Cuetos, Fernando. Universidad de Oviedo; España  
dc.description.fil
Fil: Matias Guiu, Jordi. Hospital Clínico San Carlos; España  
dc.journal.title
Journal of Alzheimer's Disease  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://journals.sagepub.com/doi/10.1177/13872877241284199  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1177/13872877241284199